Calcium dobesilate tablets 250 mg

Calcium dobesilate tablets 250 mg Medicine

Contraindications

No.

Undesirable effects

Not identified.

Therapeutic indications

Diabetic angiopathies, glomerulosclerosis, atherosclerosis of the vessels of the lower extremities, thrombophlebitis of the superficial veins, violation of the hemodynamics of arteriovenous origin.

Pharmacotherapeutic group

  • Antiplatelet Agents
  • Angioprotectors and microcirculation correctors

Special precautions for storage

In a dry, dark place.

Keep out of reach of children.

Shelf life of the preparation of Calcium dobezilate tablets 250 mg2 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

1 tablet contains calcium dobesilate 250 mg, in a package of 50 and 100 pcs.

Fertility, pregnancy and lactation

Possible.

Nosological classification (ICD-10)

  • I70. 9 Generalized and unspecified atherosclerosis
  • I79. 2 Peripheral angiopathy in diseases classified elsewhere
  • I80 Phlebitis and thrombophlebitis

Dosage (Posology) and method of administration

Inside, after meals-1 tablet 3 times a day. The course is from 3 weeks (for phlebopathies) to 6-8 months.

ATC - Anatomical and therapeutic chemical classification

C05BX01 Calcium dobesilate